S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The "Smart Money" Is Ready for May 1st Are You? (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Biden’s $374B Giveaway Into This Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The "Smart Money" Is Ready for May 1st Are You? (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Biden’s $374B Giveaway Into This Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The "Smart Money" Is Ready for May 1st Are You? (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Biden’s $374B Giveaway Into This Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The "Smart Money" Is Ready for May 1st Are You? (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Biden’s $374B Giveaway Into This Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
OTCMKTS:CSLLY

CSL (CSLLY) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free CSLLY Stock Alerts
$86.92
0.00 (0.00%)
(As of 04/19/2024 ET)
Compare
Today's Range
$85.98
▼
$87.10
50-Day Range
$86.82
▼
$94.72
52-Week Range
$71.51
▼
$105.11
Volume
59,588 shs
Average Volume
35,374 shs
Market Capitalization
$84.01 billion
P/E Ratio
N/A
Dividend Yield
1.25%
Price Target
N/A
Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest

CSL MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.44mentions of CSL in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.97%
From $3.15 to $3.59 Per Share

Overall MarketRank™

New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.48 out of 5 stars

See Top Rated MarketRank™ Stocks Here
CSLLY stock logo

About CSL Stock (OTCMKTS:CSLLY)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

CSLLY Stock Price History

CSLLY Stock News Headlines

April 3, 2024 | marketbeat.com
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment (CSLLY)
Akebia Therapeutics Inc. (NASDAQ: AKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia
April 17, 2024 | americanbankingnews.com
Artelo Biosciences (NASDAQ:ARTL) versus CSL (OTCMKTS:CSLLY) Financial Review
April 19, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
April 16, 2024 | msn.com
How much do you need to invest in CSL shares for $8,000 in annual dividends?
April 12, 2024 | markets.businessinsider.com
UBS Sticks to Their Buy Rating for CSL (CMXHF)
April 12, 2024 | americanbankingnews.com
CSL Limited (OTCMKTS:CSLLY) Short Interest Update
April 9, 2024 | afr.com
Macquarie brokers say CSL is heading to $500 per share
April 5, 2024 | investorplace.com
CSLR Stock Earnings: Complete Solaria Beats EPS, Misses Revenue for Q4 2023
April 19, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
April 2, 2024 | fool.com.au
Own CSL shares? You're receiving a healthy dividend boost today!
March 28, 2024 | finance.yahoo.com
Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients
March 26, 2024 | afr.com
Blood giant CSL works up $US1 billion-plus bond deal; banks mandated
March 11, 2024 | finance.yahoo.com
CSL Ltd's Dividend Analysis
March 6, 2024 | prnewswire.com
CSL Seqirus is Fully Prepared to Implement the FDA's Vaccines and Related Biological Products Advisory Committee Trivalent Influenza Vaccines Strain Selection for the 2024/25 U.S. Season
February 15, 2024 | markets.businessinsider.com
Wilsons downgrades CSL (CMXHF) to a Hold
February 13, 2024 | fool.com.au
CSL shares tumble despite first-half earnings beat
February 13, 2024 | afr.com
What we learnt from CSL, Challenger, Seek and Breville’s results
February 13, 2024 | finanznachrichten.de
CSL Limited: Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³
February 12, 2024 | fool.com.au
CSL share price on watch amid 20% profit jump
February 12, 2024 | marketwatch.com
CSL Says 1H Profit Rises, Boosts Dividend -- Update
February 12, 2024 | afr.com
CSL shrugs off trial setback to post double-digit earnings growth
February 12, 2024 | wsj.com
CSL Profit Rises, Boosts Dividend
February 12, 2024 | msn.com
CSL Limited falls after Phase 3 setback for key trial
February 12, 2024 | msn.com
Asian stocks move little in holiday-thinned trade; CSL drags on Australia
February 6, 2024 | msn.com
CSL and Arcturus’ Covid-19 booster found to prolong immunity
February 5, 2024 | finance.yahoo.com
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
January 29, 2024 | fool.com.au
Are CSL shares set for an earnings boost?
See More Headlines
Receive CSLLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CSLLY
CUSIP
N/A
CIK
1274152
Web
www.csl.com.au
Phone
(139) 389-1911
Fax
61-3-9389-1434
Employees
32,000
Year Founded
1904

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$13.31 billion
Price / Sales
6.31
Cash Flow
$3.10 per share
Price / Cash Flow
28.05
Book Value
$18.48 per share
Price / Book
4.70

Miscellaneous

Outstanding Shares
966,510,000
Free Float
N/A
Market Cap
$84.01 billion
Optionable
Not Optionable
Beta
0.73
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Paul F. McKenzie Ph.D. (Age 58)
    MD, CEO & Executive Director
    Comp: $2.75M
  • Ms. Joy Carolyn Linton B.Com. (Age 59)
    BComm, GAICD, Grad Dip AFI, Chief Financial Officer
    Comp: $2.05M
  • Mr. Mark Dehring
    Head of Investor Relations
  • Mr. Gregory Boss B.S. (Age 63)
    BS(Hons), J.D., Executive VP of Legal & General Counsel
    Comp: $1.1M
  • Christina Hickie
    Senior Manager of Communications
  • Ms. Roanne Parry
    Chief Human Resources Officer
  • Dr. Karen Etchberger (Age 66)
    Executive Vice President of Quality & Business Services
    Comp: $1.03M
  • Ms. Jemimah Brennan
    Head of Communications - Asia Pacific
  • Dr. Andrew D. Nash BSc (Hons) (Age 62)
    GAICD, Ph.D., Senior Vice President of Research
  • Dr. William Mezzanotte M.D. (Age 65)
    M.P.H., Executive VP & Head of Research and Development
    Comp: $1.46M

Key Competitors

View All Competitors

Should I Buy CSL Stock? CSLLY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in CSL Limited:

  • CSL Limited operates in the pharmaceutical preparations industry, which is known for its stability and potential for growth.
  • CSL Limited has a diverse product portfolio, including plasma products, gene therapies, and vaccines, which can provide revenue streams from various sources.
  • Recent developments have shown CSL Limited's commitment to research and development, ensuring a pipeline of innovative products for the future.
  • CSL Limited's stock price has shown resilience and potential for growth, with a recent price of $97.17 on record date 12/31/2023.
  • CSL Limited has a global presence, operating in multiple countries, which can help mitigate risks associated with regional economic fluctuations.

Cons

Investors should be bearish about investing in CSL Limited for these reasons:

  • CSL Limited's outstanding shares information is not available, which may indicate limited transparency into the company's ownership structure.
  • CSL Limited's institutional ownership percentage is currently at 0, which may raise concerns about institutional confidence in the company.
  • CSL Limited's short percentage of float is 0, which may indicate limited interest from short-term investors in the company's stock.
  • CSL Limited's month-to-month change percentage in shares shorted was -0.2638, which may suggest a bearish sentiment among some investors.
  • CSL Limited's float size is 0, which may raise questions about the liquidity of the company's shares in the market.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, April 13, 2024. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com.

CSLLY Stock Analysis - Frequently Asked Questions

How have CSLLY shares performed in 2024?

CSL's stock was trading at $97.17 on January 1st, 2024. Since then, CSLLY shares have decreased by 10.6% and is now trading at $86.9180.
View the best growth stocks for 2024 here.

Are investors shorting CSL?

CSL saw a increase in short interest in March. As of March 31st, there was short interest totaling 8,600 shares, an increase of 65.4% from the March 15th total of 5,200 shares. Based on an average daily trading volume, of 55,100 shares, the days-to-cover ratio is currently 0.2 days.
View CSL's Short Interest.

Is CSL a good dividend stock?

CSL (OTCMKTS:CSLLY) pays an annual dividend of $1.09 per share and currently has a dividend yield of 1.24%.
Read our dividend analysis for CSLLY.

How do I buy shares of CSL?

Shares of CSLLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CSLLY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Options trading has suddenly become more reliable.
Eagle Publishing
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends